pharmaceutical consulting companies
Quality Assurance Consulting
Latest Update From: The Indian Central Drugs Standard Control Organization
Originally established in 1997 to meet the need for independent Good Clinical Practice auditing, following the introduction of ICH E6, ADAMAS has expanded its services to include all the pharmaceutical good practices.
GxP, Mock Inspection, QMS related services.
Our values and reason for being. Clarity, Integrity, Excellence.
Vision, Experience, Understanding, Global Reach
Contact ADAMAS Consulting to discuss your requirements.
ADAMAS provides an excellent service to our company, primarily as they always understand our requirements and deliver solutions without fuss and to the highest standard.
President, European R D, Global Pharma
From the small biotech start-up to the largest pharmaceutical companies in the world, ADAMAS has advised and supported hundreds of organisations through their compliance journey.
Tel: +44 (0)1344 751 210 Email: [email protected] – © 2016 ADAMAS Consulting All Rights Reserved – Designed & Created by Engage Convert Ltd
ADAMAS Consulting Limited is a company registered in England & Wales – Company Number 3403717 – VAT No 700626572
Registered Address: ADAMAS Consulting, 7 Wellington Business Park, Dukes Ride, Crowthorne, Berkshire, RG45
Brochure Please download the ADAMAS brochure describing our QA services and contact details.
The development of medicines is the most regulated industry in the world, and compliance at each stage of the research and development process, as well as after licensing, is critical to ensuring high quality and safe medicines reach patients in a timely manner.
ADAMAS’s consultants have expertise across the G’X’Ps in pre-clinical, clinical and post-licensing areas. They have worked across many different therapeutic areas and product types including oncology, vaccines, biologics, medical devices and gene therapy. As a company we have developed close partnerships with our clients to support them in their development programmes and post-licensing activities, and to guide them successfully through their worldwide regulatory inspections.